Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kate Ida Lathrop"'
Autor:
Hakim Bouamar, Larry Esteban Broome, Kate Ida Lathrop, Ismail Jatoi, Andrew Jacob Brenner, Alia Nazarullah, Karla Moncada Gorena, Michael Garcia, Yidong Chen, Virginia Kaklamani, Lu-Zhe Sun
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-17 (2023)
Abstract Background Mammary physiology is distinguished in containing adult stem/progenitor cells that are actively amending the breast tissue throughout the reproductive lifespan of women. Despite their importance in both mammary gland development,
Externí odkaz:
https://doaj.org/article/af828a1e508a42038a1d750d30efc69a
Autor:
Kate Ida Lathrop, Michael E Auster, Brian Warnecke, Lakene Raissa Djoufack Djoumessi, Jean-Pierre Blaize, Abhishek Pandya, Michelle Janania Martinez
Publikováno v:
Journal of Clinical Oncology. 38:135-135
135 Background: Young adults undergoing cancer treatment often face increased risk of infertility. Despite current ASCO guidelines recommending prompt fertility preservation education, knowledge about prevalence and barriers to oncofertility care is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0762276242dee6bf60c9aa52eaa676e
https://doi.org/10.1200/jco.2020.38.29_suppl.135
https://doi.org/10.1200/jco.2020.38.29_suppl.135
Autor:
Marisa Rodriguez, Kate Ida Lathrop, Virginia G. Kaklamani, Alia Nazarullah, Andrew Brenner, Jonathan Gelfond, Sarah Hackman, Courtney Thomas, Richard M. Elledge, Rong Li
Publikováno v:
Journal of Clinical Oncology. 38:560-560
560 Background: Patients with TNBC breast cancer have inferior treatment outcomes compared to other breast cancer subtypes and targeted therapies are lacking. S-equol is a novel oral Estrogen Receptor (ER) Beta agonist with preclinical data showing s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db289ea0c4ecd1048dd59833d96cc7ad
https://doi.org/10.1200/jco.2020.38.15_suppl.560
https://doi.org/10.1200/jco.2020.38.15_suppl.560
Autor:
Kate Ida Lathrop, Ryan Williams, Kelly Pippin, James H. K. Yoo, Jean-Pierre Blaize, Brian Warnecke, Travis M. Cox, Christine Ann Moore, Lakene Raissa Djoufack Djoumessi, Flavia Fernandes, Madison H. Williams, Sushanth Kakarla, Michelle Janania Martinez, Juan Garza, Prathibha Surapaneni, Tyler William Snedden
Publikováno v:
Journal of Clinical Oncology. 38:e17059-e17059
e17059 Background: Hispanics (HI) are the fastest growing ethnic group in the US, representing 52% of US population growth from 2010-2018. In the past decade, they have also experienced a rise in incidence of testicular cancer. Studies have shown tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b4b0a186e725640a7f9d8c0ab49e077
https://doi.org/10.1200/jco.2020.38.15_suppl.e17059
https://doi.org/10.1200/jco.2020.38.15_suppl.e17059
Autor:
Faraz Fiazuddin, Kate Ida Lathrop, Jessica Trevino Jones, Michelle Janania Martinez, Uzair Mushtaq
Publikováno v:
Journal of Clinical Oncology. 35:232-232
232 Background: Research has established that woman with a history of lymphoma who receive chest wall radiation are at a greater risk to develop breast cancer. As such, recommendations for breast cancer screening for woman who received prior RT < 30y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::838ff7881494143c5244c64de3ce197d
https://doi.org/10.1200/jco.2017.35.5_suppl.232
https://doi.org/10.1200/jco.2017.35.5_suppl.232
Autor:
Jonathan Gelfond, Marcela Mazo Canola, Stephanie Purkat Lindauer, Jessica Trevino Jones, Barbara Hinojosa, Kate Ida Lathrop
Publikováno v:
Journal of Clinical Oncology. 35:8-8
8 Background: The financial cost of cancer is a large burden and continues to rise substantially. Expenditures can be divided into the initial phase after diagnosis, the continuing phase, and the last year of life. Typically costs are greatest in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9469d142c273d13be38ffb68c89f624f
https://doi.org/10.1200/jco.2017.35.5_suppl.8
https://doi.org/10.1200/jco.2017.35.5_suppl.8
Autor:
Jonathan Gelfond, Barbara Hinojosa, Katherine A. Terracina, Jay C Shiao, Marcela Mazo Canola, Kate Ida Lathrop
Publikováno v:
Journal of Clinical Oncology. 33:146-146
146 Background: Oncotype DX is an RT-PCR based assay that calculates a recurrence score (RS) to predict chemotherapy benefit in patients with breast cancer. Some authors have proposed using Ki-67, receptor status, Nottingham grade, and tumor size as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6106f41744fa6693835fd6429e07e999
https://doi.org/10.1200/jco.2015.33.28_suppl.146
https://doi.org/10.1200/jco.2015.33.28_suppl.146
Autor:
Kate Ida Lathrop, Marcela Mazo- Canola, Jonathan Gelfond, Jay C Shiao, Barbara Hinojosa, Katherine A Terracina
Publikováno v:
Journal of Clinical Oncology. 33:e11558-e11558
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bc1eb49c571b13d44ca4286a5a56a66
https://doi.org/10.1200/jco.2015.33.15_suppl.e11558
https://doi.org/10.1200/jco.2015.33.15_suppl.e11558